Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Personalizing treatment for mCRC in 2022

Impact of locoregional treatments in the metastatic setting

Date

12 Sep 2022

Session

Personalizing treatment for mCRC in 2022

Topics

Clinical Research;  Cytotoxic Therapy;  Multi-Disciplinary and Multi-Professional Cancer Care;  Surgical Oncology;  Image-Guided Therapy

Tumour Site

Colon and Rectal Cancer

Presenters

Pieter Tanis

Authors

P. Tanis

Author affiliations

  • Surgical Oncology And Gastrointestinal Surgery, Erasmus MC Cancer Institute, 3015 GD - Rotterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.